Efficacy of electrochemotherapy in ulcerated basal cell carcinoma. 2011

A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
Department of Dermatology, Umberto I Hospital, University Sapienza, Rome, Italy. antoniorichetta@hotmail.com

Basal cell carcinoma is the most common cutaneous malignant tumor, accounting for up to 80% of non melanoma skin cancers. Surgery, radiotherapy and chemotherapy have been for long time the main options for its treatment. Electrochemotherapy (ECT) is a novel local treatment successfully used in primary skin tumors. We report a case of a man affected by ulcerated basal cell carcinoma treated with ECT. In our case ECT was successful in the management of extensive basal cell carcinoma in clinical conditions whereas other approaches, would have been dangerous and inappropriate. To our knowledge, ECT must be considered as an alternative of traditional techniques when they are contraindicated in relation to the appearance of the lesions or the patient medical history.

UI MeSH Term Description Entries
D008297 Male Males
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
January 1996, Journal of the American Academy of Dermatology,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
October 2017, Open access Macedonian journal of medical sciences,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
May 2017, Journal of translational medicine,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
February 2015, Melanoma management,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
September 1996, Clinical and experimental dermatology,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
October 1997, Journal of the American Academy of Dermatology,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
January 2014, Indian journal of dermatology, venereology and leprology,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
March 2021, JPRAS open,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
May 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
A G Richetta, and P Curatolo, and S D'Epiro, and M Mancini, and C Mattozzi, and S Giancristoforo, and R Rotunno, and S Calvieri
March 2011, Journal of drugs in dermatology : JDD,
Copied contents to your clipboard!